CEBPG and cancer: Most notably, meticulous analysis proved that circFoxp1 on exosomes can inhibit miR-22 and miR-150-3p, leading to increased expression of two genes, CCAAT enhancer binding protein gamma (CEBPG) and formin-like 3 (FMNL3), which may affect the resistance of cancer cells to cisplatin [47].